Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old

Human papillomavirus (HPV) infection can lead to significant disease in males, including anogenital warts, intraepithelial neoplasias, and several types of oral and anogenital cancers. The quadrivalent HPV (type 6/11/16/18) L1 virus-like particle (VLP) vaccine (qHPV vaccine; Gardasil) has recently b...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Hillman, Richard J., Giuliano, Anna R., Palefsky, Joel M., Goldstone, Stephen, Moreira, Edson D., Vardas, Eftyhia, Aranda, Carlos, Jessen, Heiko, Ferris, Daron G., Coutlee, Francois, Marshall, J. Brooke, Vuocolo, Scott, Haupt, Richard M., Guris, Dalya, Garner, Elizabeth I. O.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2012
Предметы:
Vaccines
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3272915/
https://ncbi.nlm.nih.gov/pubmed/22155768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.05208-11
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы